Showing results (51-60 of 537) with videos related to
Sort By:
Pageof 54
Infection|January 1, 1994
In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilliM Michéa-Hamzehpour, A Kahr, J C PechèreBulletin De L'Academie Nationale De Medecine|July 22, 1998
[Antibiotic efflux, a mechanism of multiple resistance in Pseudomonas aeruginosa]J C Pechère, M Michéa-Hamzhepour, T KöhlerThe Journal of Antimicrobial Chemotherapy|September 1, 1989
Determinants of efficacy and toxicity of aminoglycosidesH Mattie, W A Craig, J C PechèreCanadian Medical Association Journal|February 17, 1979
Restrictive antibiotherapy after renal transplantationS Langlois, J C Pechère, J G LachanceThe Journal of Antimicrobial Chemotherapy|April 1, 1986
In-vitro activity of newer quinolones against aerobic bacteriaR Auckenthaler, M Michéa-Hamzehpour, J C PechèreInternational Journal of Antimicrobial Agents|November 24, 1999
Evaluation of trimethoprim and sulphamethoxazole as monotherapy or in combination in the management of toxoplasmosis in murine modelsJ L Dumas, G Pizzolato, J C PechèreAntimicrobial Agents and Chemotherapy|May 1, 1976
Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patientsJ C Pechère, M M Pechère, R DugalAntimicrobial Agents and Chemotherapy|January 1, 1991
Novel method for measurement of outer membrane permeability to new beta-lactams in intact Enterobacter cloacae cellsF Bellido, J C Pechère, R E HancockAntimicrobial Agents and Chemotherapy|May 1, 1990
In vitro and in vivo effects of doxycycline on Toxoplasma gondiiH R Chang, R Comte, J C PechèreAntimicrobial Agents and Chemotherapy|January 1, 1991
Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacaeF Bellido, J C Pechère, R E HancockPageof 54